NDRA
ENDRA Life Sciences Inc.
Key Financials
Net Income
$-7027410
↑ 38.9%
Operating Income
$-5763101
↑ 46.7%
Gross Profit
$0
NaN%
Revenue
$0
NaN%
EPS (Diluted)
$-8.93
↑ 84.3%
Shareholders' Equity
$2.3M
↓ 11.7%
Total Liabilities
$1.6M
↓ 15.8%
Cash & Equivalents
$4.8M
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 8-K | 3/25/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 1/23/2026 | View on SEC |
| 4 | 1/23/2026 | View on SEC |
| 4 | 1/23/2026 | View on SEC |
| 4 | 1/23/2026 | View on SEC |
| 4 | 1/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NDRA |
| Company Name | ENDRA Life Sciences Inc. |
| CIK | 1681682 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 734-335-0468 |